State of New Jersey Common Pension Fund D Sells 92 Shares of Axon Enterprise, Inc $AXON

State of New Jersey Common Pension Fund D lowered its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 0.4% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 24,771 shares of the biotechnology company’s stock after selling 92 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Axon Enterprise were worth $20,509,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. TCTC Holdings LLC lifted its position in shares of Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after purchasing an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC raised its stake in Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after buying an additional 33 shares in the last quarter. Banque Transatlantique SA purchased a new stake in Axon Enterprise in the first quarter worth about $31,000. Catalyst Capital Advisors LLC bought a new stake in Axon Enterprise during the 1st quarter valued at approximately $32,000. Finally, Flaharty Asset Management LLC purchased a new position in shares of Axon Enterprise during the 1st quarter worth approximately $33,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on AXON shares. Bank of America upped their price target on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. JMP Securities reaffirmed a “market outperform” rating and issued a $825.00 target price on shares of Axon Enterprise in a research report on Monday, September 29th. Needham & Company LLC reissued a “buy” rating and set a $870.00 price target on shares of Axon Enterprise in a research report on Wednesday, September 24th. UBS Group restated a “neutral” rating and issued a $840.00 price objective (up previously from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Finally, Morgan Stanley set a $885.00 target price on shares of Axon Enterprise and gave the company an “overweight” rating in a report on Friday, July 11th. Fourteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $841.64.

Insider Transactions at Axon Enterprise

In other news, President Joshua Isner sold 15,919 shares of the company’s stock in a transaction on Friday, August 15th. The stock was sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the transaction, the president directly owned 238,379 shares of the company’s stock, valued at $177,892,712.54. This represents a 6.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Brittany Bagley sold 5,000 shares of the stock in a transaction on Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the sale, the chief financial officer directly owned 93,592 shares in the company, valued at $66,813,456.96. This trade represents a 5.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 59,932 shares of company stock valued at $45,115,616. Insiders own 4.40% of the company’s stock.

Axon Enterprise Stock Up 2.7%

Shares of Axon Enterprise stock opened at $735.95 on Friday. The company has a 50-day simple moving average of $733.17 and a two-hundred day simple moving average of $725.28. The stock has a market capitalization of $57.77 billion, a PE ratio of 181.72, a price-to-earnings-growth ratio of 28.58 and a beta of 1.41. Axon Enterprise, Inc has a 52-week low of $422.38 and a 52-week high of $885.91. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. During the same quarter last year, the firm earned $1.20 earnings per share. The firm’s quarterly revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. On average, analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.